Published in Clinical Oncology Week, June 30th, 2003
"We examined the biological and antitumor activity of a series of dinuclear ruthenium complexes. The aim of this study was to compare the in vitro effects of these new compounds on cell proliferation, cell distribution among cell cycle phases, and the expression of some proteins involved in cell cycle regulation.
"Results obtained show a mild cytotoxic activity against human and murine cell lines, more evident after prolonged exposure of cell challenge," scientists writing in the Journal of Pharmacology and Experimental...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.